Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
India · Delayed Price · Currency is INR 915.10
-3.00 (-0.33%)
Dec 18, 2025, 10:10 AM IST
Zydus Lifesciences Market Cap
Zydus Lifesciences has a market cap or net worth of 923.82 billion as of December 17, 2025. Its market cap has decreased by -3.23% in one year.
Market Cap
923.82B
Enterprise Value
977.38B
Revenue
244.94B
Ranking
n/a
PE Ratio
18.78
Stock Price
915.10
Market Cap Chart
Since May 15, 2002, Zydus Lifesciences's market cap has increased from 8.20B to 923.82B, an increase of 11,171.93%. That is a compound annual growth rate of 22.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 920.05B | -5.90% |
| Dec 31, 2024 | 977.76B | 40.16% |
| Dec 29, 2023 | 697.61B | 64.11% |
| Dec 30, 2022 | 425.08B | -14.06% |
| Dec 31, 2021 | 494.62B | 1.34% |
| Dec 31, 2020 | 488.07B | 87.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.27T |
| Divi's Laboratories | 1.68T |
| Cipla | 1.21T |
| Apollo Hospitals Enterprise | 995.21B |
| Mankind Pharma | 869.37B |
| Aurobindo Pharma | 684.24B |
| Alkem Laboratories | 677.16B |
| Fortis Healthcare | 657.53B |